SELF-ASSEMBLY FOR ACTIVATING IMMUNITY

Title:

SELF-ASSEMBLY FOR ACTIVATING IMMUNITY

Document Type and Number:

WIPO Patent Application WO/2020/045570

Kind Code:

A1

Abstract:

Provided are: a novel compound that forms a self-assembly; the self-assembly; production methods for the compound and the self-assembly; and pharmaceutical use of the compound and the self-assembly. The compound is represented by formula (I) [in the formula, Rx represents H or a group represented by formula (II), Ry represents H or a group represented by formula (III), R1, R2, R3, and R4 each independently represent H, C1-6 alkyl, or C1-6 haloalkyl, a wavy line represents a binding site, and n represents an integer of 1-12]. The self-assembly is formed by the composition. The production methods are for the compound and the self-assembly, and the pharmaceutical use are for the compound and the self-assembly.

More Like This:

WO/2004/012732	USE OF A PROTEASOME INHIBITOR IN THE TREATMENT OF ENDOTHELIAL DYSFUNCTION AND/OR IN A LOW-DOSE PROTEASOME INHIBITOR THERAPY
WO/1999/067278	PRODRUGS OF DIPEPTIDYL PEPTIDASE IV INHIBITORS
WO/2024/063223	PHARMACEUTICAL COMPOSITION CONTAINING MITOCHONDRIA-TARGETING COMPOUND AS ACTIVE INGREDIENT FOR TREATING MACULAR DEGENERATION

Inventors:

UESUGI MOTONARI (JP)
VU HUE T (JP)
YOSHIDA HIROKI (JP)
NODA NAOTAKA (JP)
JIN SHUYU (JP)
YAMASAKI SHO (JP)
SHIMANE TORU (JP)
ISHII KEN (JP)
HIOKI KOU (JP)

Application Number:

PCT/JP2019/033920

Publication Date:

March 05, 2020

Filing Date:

August 29, 2019

Export Citation:

Click for automatic bibliography generation Help

Assignee:

UNIV KYOTO (JP)
UNIV OSAKA (JP)

International Classes:

A61K38/07; A61K31/575; A61K39/00; A61K39/39; A61K47/62; A61P9/12; A61P25/28; A61P31/00; A61P35/00; A61P37/02; A61P37/04; A61P37/08; C07J9/00; C07K5/02

Domestic Patent References:

WO2015079952A1

2015-06-04

Foreign References:

US20050222115A1	2005-10-06
US20060003974A1	2006-01-05

Other References:

SALUNKE, DEEPAK B. ET AL.: "New steroidal dimers with antifungal and antiproliferative activity", JOURNAL OF MEDICINAL CHEMISTRY, vol. 47, no. 6, 2004, pages 1591 - 1594, XP055697288
LI, YAN ET AL.: "Design, synthesis and antitumor activity of dimeric bile acid-amino acid conjugates", LETT IN ORG CHEM, vol. 4, no. 6, 2007, pages 414 - 418, XP055697317
OYAMA, SHOHEI ET AL.: "The necessity and safety of vaccine adjuvant", JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, vol. 234, no. 3, 2010, pages 217 - 221

Attorney, Agent or Firm:

YAMAO, Norihito et al. (JP)

Download PDF:

View/Download PDF PDF Help

Previous Patent: CLADDING MODE LIGHT REMOVAL STRUCTURE, LASER DEVICE, AND METHOD FOR MANUFACTURING CLADDING MODE LIGH...

Next Patent: PRODUCTION METHOD FOR CRYSTAL OF REDUCED COENZYME Q10 HAVING EXCELLENT STABILITY